Search

everythinglearnresearchcommunity

for

Search:↓

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Infrared radiation can cause skin aging and cancer at high temperatures but may have therapeutic benefits at controlled levels.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Hydrogel microneedles offer a promising, minimally invasive way to treat diseases like cancer and hair loss, but need improvements in strength and standardization.

Microneedles improve drug delivery, patient compliance, and have potential in cancer treatment and skin care.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Personalized treatment and teamwork among doctors can reduce chemotherapy side effects and improve patient outcomes.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Using drugs to activate the Wnt/β-catenin pathway has potential for treating diseases but also presents challenges.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Disruptions in sleep-wake cycles can cause health problems like mental, metabolic, and heart diseases, and cancer.

Gefitinib therapy can cause unusual hair growth on the nose.

Targeted photodynamic therapy is a promising method for precise disease treatment and diagnosis.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Developing microRNA-based treatments is hard but has potential.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

A dog's skin and digestive problems improved after treatment for thyroid cancer.

Prednisolone improved symptoms in a woman with Cronkhite-Canada syndrome, but regular screenings are needed due to cancer risk.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

S100A6 protein is linked to disease progression, especially in cancers.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.